On April 9, three groups sent a letter to the Centers for Medicare and Medicaid Services, requesting that CMS use alleged statutory authority to allow companies to make and sell generic versions of prostate cancer drug, Xtandi®.
President Biden wants to force drug companies to lower prices by threatening to share their innovations with competing companies if they don't comply with his price caps.
WASHINGTON (Reuters) - The U.S. government will not force Pfizer Inc and Astellas Pharma Inc to lower the price of their prostate cancer drug Xtandi u.